Uitrakul, S.; Aksonnam, K.; Srivichai, P.; Wicheannarat, S.; Incomenoy, S.
The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study. Medicines 2022, 9, 59.
https://doi.org/10.3390/medicines9120059
AMA Style
Uitrakul S, Aksonnam K, Srivichai P, Wicheannarat S, Incomenoy S.
The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study. Medicines. 2022; 9(12):59.
https://doi.org/10.3390/medicines9120059
Chicago/Turabian Style
Uitrakul, Suriyon, Krittika Aksonnam, Pimchanok Srivichai, Sorawit Wicheannarat, and Supatcha Incomenoy.
2022. "The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study" Medicines 9, no. 12: 59.
https://doi.org/10.3390/medicines9120059
APA Style
Uitrakul, S., Aksonnam, K., Srivichai, P., Wicheannarat, S., & Incomenoy, S.
(2022). The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study. Medicines, 9(12), 59.
https://doi.org/10.3390/medicines9120059